- ￥819 - 1404
- Biorbyt
- 英国
- orb1909116
- 2026年08月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起，权威机构信任 15+ 年Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
详询
- 保质期：
12 months from date of receipt.
- 英文名：
Antibacterial agent 18
- 库存：
99
- 供应商：
Biorbyt
- CAS号：
1239602-35-7
- 规格：
1 ml x 10 mM (in DMSO)/500 mg/1 g
| 规格： | 1 ml x 10 mM (in DMSO) | 产品价格： | ￥819.0 |
|---|---|---|---|
| 规格： | 500 mg | 产品价格： | ￥1053.0 |
| 规格： | 1 g | 产品价格： | ￥1404.0 |
描述: Antibacterial agent 18 is a multi-arm AIEgen that disrupts bacterial cell wall synthesis by interfering with glycosylation and transpeptidation. It exhibits broad-spectrum activity against gram-positive and gram-negative bacteria, making it a useful tool for studying bacterial infections in both in vitro and in vivo research models.
别名: Antibacterial agent 18
靶点: Antibacterial
分子式: C39H27NO6
分子量: 605.64
纯度: 98.08% (May vary between batches)
SMILES: O=C(O)C1=CC=C(C=C1)C2=CC=C(C=C2)N(C3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)O)C5=CC=C(C=C5)C6=CC=C(C=C6)C(=O)O
溶解度: DMSO:16 mg/mL (26.42 mM)
研究领域: Infectious Disease & Virology
保存条件: -20°C
备注: For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Genomic Approaches to Antibacterial Discovery
of concept in curing experimental infections. The second approach is based on screening for compounds with antibacterial activity and then employing a broad variety of newer technologies to identify the molecular target of the antibacterial agent
Methods to Assay Inhibitors of tRNA Synthetase Activity
could be a potential antibacterial agent. Only one aa-RS inhibitor, the Ile-RS inhibitor mupirocin, is currently marketed as an antibacterial agent. We focused on phenylalanyl (Phe)-tRNA synthetase (Phe-RS), but the described methods are not restricted to Phe-RS
Assessing the Activity of Bacterial Multidrug Efflux Pumps
Resistance to antibiotics in target bacterial populations has long complicated antibacterial chemotherapy. First described in the early 1980s (1 , 2 ), efflux mechanism of resistance, whereby the antibiotic is actively (i.e., in an energy
技术资料暂无技术资料 索取技术资料
